Moderna Affirms FY2026 Sales Guidance of $2.138B vs $2.089B Est
Moderna (NASDAQ:MRNA) affirms FY2026 sales outlook from $2.138 billion to $2.138 billion vs $2.089 billion estimate.
Share
Why It Matters
Moderna says it will make about $2.138 billion next year, which is a bit more than what other people guessed ($2.089 billion). This means the company feels confident about its business plans staying on track.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.